SG49785A1 - Use of 17 alpha dihydroequilenin for lowering cholesterol - Google Patents

Use of 17 alpha dihydroequilenin for lowering cholesterol

Info

Publication number
SG49785A1
SG49785A1 SG1996005818A SG1996005818A SG49785A1 SG 49785 A1 SG49785 A1 SG 49785A1 SG 1996005818 A SG1996005818 A SG 1996005818A SG 1996005818 A SG1996005818 A SG 1996005818A SG 49785 A1 SG49785 A1 SG 49785A1
Authority
SG
Singapore
Prior art keywords
lowering cholesterol
dihydroequilenin
alpha
alpha dihydroequilenin
hyperlipidemia
Prior art date
Application number
SG1996005818A
Other languages
English (en)
Inventor
Scott Alan Waschburn
Thomas Boston Clarkson
Steven Jay Adelman
Michael Jay Dey
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of SG49785A1 publication Critical patent/SG49785A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG1996005818A 1992-11-02 1993-11-01 Use of 17 alpha dihydroequilenin for lowering cholesterol SG49785A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US97034892A 1992-11-02 1992-11-02

Publications (1)

Publication Number Publication Date
SG49785A1 true SG49785A1 (en) 1998-06-15

Family

ID=25516811

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996005818A SG49785A1 (en) 1992-11-02 1993-11-01 Use of 17 alpha dihydroequilenin for lowering cholesterol

Country Status (16)

Country Link
US (1) US5510342A (fr)
EP (1) EP0666747B1 (fr)
JP (1) JP3621095B2 (fr)
CN (1) CN1089238C (fr)
AT (1) ATE204755T1 (fr)
AU (1) AU5544994A (fr)
CA (1) CA2148357A1 (fr)
DE (1) DE69330680T2 (fr)
DK (1) DK0666747T3 (fr)
ES (1) ES2161750T3 (fr)
IL (1) IL107343A (fr)
PT (1) PT666747E (fr)
SG (1) SG49785A1 (fr)
TW (1) TW237385B (fr)
WO (1) WO1994009789A1 (fr)
ZA (1) ZA938016B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19524937A1 (de) * 1995-07-08 1997-01-09 Jenapharm Gmbh Pharmazeutische Präparate zur Prophylaxe und Therapie radikalvermittelter Zellschädigungen und zur medikamentösen Substitution beim Mann
US5719137A (en) * 1996-12-03 1998-02-17 Wake Forest University Method of preventing neurodegeneration and cognitive dysfunction using 17α-dihydroequilenin
US7022688B1 (en) 1996-12-10 2006-04-04 Wyeth Use of 17β-dihydroequilenin as an antioxidant
TW422693B (en) * 1996-12-10 2001-02-21 American Home Prod 17<beta>-dihydroequilenin as an antioxidant
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
SG154323A1 (en) * 2001-03-16 2009-08-28 Wyeth Corp Estrogen replacement therapy
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
CA2521471A1 (fr) * 2003-04-11 2004-10-28 Barr Laboratories, Inc. Procede d'administration d'oestrogenes et de progestatifs
WO2006084082A1 (fr) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Compositions d'oestrogenes non conjugues et procedes destines a leur utilisation
JP2009531712A (ja) * 2006-03-23 2009-09-03 デ グスマン ブレイヤー、エメリタ アポリポタンパク質フィンガープリント技術

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4154820A (en) * 1976-02-23 1979-05-15 Akzona Incorporated Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
US4729999A (en) * 1984-10-12 1988-03-08 Bcm Technologies Antiestrogen therapy for symptoms of estrogen deficiency

Also Published As

Publication number Publication date
IL107343A0 (en) 1994-01-25
DE69330680T2 (de) 2002-06-13
JP3621095B2 (ja) 2005-02-16
PT666747E (pt) 2002-02-28
AU5544994A (en) 1994-05-24
EP0666747A1 (fr) 1995-08-16
DK0666747T3 (da) 2001-12-27
EP0666747B1 (fr) 2001-08-29
DE69330680D1 (de) 2001-10-04
ATE204755T1 (de) 2001-09-15
WO1994009789A1 (fr) 1994-05-11
CA2148357A1 (fr) 1994-05-11
ES2161750T3 (es) 2001-12-16
IL107343A (en) 2003-10-31
CN1094283A (zh) 1994-11-02
TW237385B (fr) 1995-01-01
ZA938016B (en) 1995-04-28
US5510342A (en) 1996-04-23
CN1089238C (zh) 2002-08-21
JPH08503702A (ja) 1996-04-23

Similar Documents

Publication Publication Date Title
SG49785A1 (en) Use of 17 alpha dihydroequilenin for lowering cholesterol
EP0960628A4 (fr) Seringue servant egalement d&#39;ampoule et seringue de prelevement sanguin
AR244094A1 (es) Dispositivo de cateter para impedir el derrame de sangre.
AU1352188A (en) Mixtures for treating hypercholesterolemia
EP0514553A4 (en) Antipruritic drug and antipruritic composition
GEP20033006B (en) Sugar-Substituted 2-Azetidinones Useful as Hypocholesterolemic Agents
HUT59944A (en) Process for producing polymeres for controlling blood cholesterol level and pharmaceutical compositions containing them
CA2040865A1 (fr) Methode visant a prevenir, stabiliser ou reduire l&#39;atherosclerose et reposant sur l&#39;utilisation conjointe d&#39;un medicament a effet hypocholesterolemiant et d&#39;un inhibiteur de l&#39;enzyme de conversion
CA2248032A1 (fr) Agent abaissant le taux de cholesterol dans le serum
ZA915659B (en) Novel piperidyl ethers and thioethers as inhibitors of cholesterol biosynthesis
ZA899446B (en) Combination of an hmg coa reductase inhibitor and other type of serum cholesterol reducing agent and method for lowering serum cholesterol using such combination
UA37199C2 (uk) Алкіламінокетони
LV10839A (lv) Arstniecibas lidzeklis lipidu un holesterina vielmainas traucejumu profilaksei un arstesanai so traucejumu profilakses un arstesanas panemiens
IL102058A0 (en) Pharmaceutical compositions containing a nucleoside derivative
EP0431763A3 (en) Therapeutic agents for lowering triglyceride and/or cholesterol levels and/or increasing hdl levels
AU7178298A (en) Magnetic resonance blood pool agents
ES2165382T3 (es) Agentes antiateroescleroticos.
SG64899A1 (en) Method and composition for treatment of patients having decompsated liver disease
RU99111758A (ru) Способ снижения уровней липопротеина (a) в плазме крови
UA30393A (uk) Спосіб лікування коронарного атеросклерозу